The Infectious Diseases Institute, established within Makerere University, is a Ugandan not-for-profit organization which aims to strengthen health systems in Africa, with a strong emphasis on infectious diseases; through research and capacity development.

During the past decade, Infectious Diseases Institute conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 3 clinical trials were completed. i.e. 15% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infectious Diseases Institute" #1 sponsor was "Makerere University" with 16 trials, followed by "University of Washington" with 10 trials sponsored, "University of Liverpool" with 5 trials sponsored, "University of Minnesota" with 4 trials sponsored and "Infectious Diseases Institute" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Diseases Institute" #1 collaborator was "Makerere University" with 12 trials as a collaborator, "Infectious Diseases Institute, Uganda" with 11 trials as a collaborator, "University of Liverpool" with 9 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 6 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Infectious Diseases Institute" are "HIV" (14 trials), "Tuberculosis" (7 trials), "Contraception" (6 trials), "HIV Infections" (6 trials) and "HIV/AIDS" (5 trials). Many other conditions were trialed in "Infectious Diseases Institute" in a lesser frequency.

Most popular intervention types in "Infectious Diseases Institute" are "Drug" (29 trials), "Behavioral" (8 trials), "Other" (8 trials), "Device" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dolutegravir" (3 trials), "Dolutegravir 50mg od" (2 trials), "Efavirenz" (2 trials), "Fluconazole" (2 trials) and "Game Changers" (2 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Diseases Institute" are 45 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Infectious Diseases Institute". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 31 completed trials in Infectious Diseases Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Diseases Institute, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 16 trials that are defined as “Not Applicable".